Abstract
This chapter provides an introduction to the biology and pathology of molecular chaperones, many of which are heat-shock proteins, involved in protein homeostasis and other unrelated functions. When chaperones are defective structurally and/or functionally they may cause disease. These diseases in which chaperones play an etiologic-pathogenic role are the chaperonopathies. The chapter also gives a clinical-pathological overview of chaperonopathies and guidelines for their identification and diagnosis. It briefly describes how to detect and characterize a chaperonopathy in a patient. Chaperones can be useful biomarkers for disease diagnosis and monitoring, including evaluation of prognosis and response to treatment. This and the potential of chaperones for therapy, i.e., chaperonotherapy, are aspects of chaperonology also outlined in the chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Further Reading
Sections 1.1–1.5 Stress and Anti-Stress Mechanisms, Including Molecular Chaperones and Their Associated Pathologies
Encyclopedia of Stress (Second Edition). Editor-in-Chief: George Fink. Associate Editors: Bruce McEwen, E. Ronald de Kloet, Robert Rubin, George Chrousos, Andrew Steptoe, Noel Rose, Ian Craig, Giora Feuerstein. Copyright © 2007 Elsevier Inc. All rights reserved. ISBN: 978-0-12-373947-6. Elsevier Saint Louis, MO, USA; Oxford, UK; Singapore; Australia; http://www.elsevierdirect.com/brochures/stress/index.html
History
Haak J, Kregel KC (2008) 1962–2007: a cell stress odyssey. Novartis Found Symp 291:3–15; discussion 15–22, 137–140
CHAPERONES IN THE MAINTENANCE OF PROTEIN HOMEOSTASIS Protein Folding, Protection from Aggregation, Dissolution of Protein Aggregates, Refolding, Translocation, Degradation, Namely, Chaperones in Protein Quality Control
Calamini B, Morimoto RI (2012) Protein homeostasis as a therapeutic target for diseases of protein conformation. Curr Top Med Chem 12:2623–2640
Clark AR, Lubsen NH, Slingsby C (2012) sHSP in the eye lens: Crystallin mutations, cataract and proteostasis. Int J Biochem Cell Biol 44:1687–1697
Easton DP, Kaneko Y, Subjeck JR (2000) The hsp110 and Grp170 stress proteins: newly recognized relatives of the Hsp70s. Cell Stress Chaperones 5:276–290
Hartl FU, Bracher A, Hayer-Hartl M (2011) Molecular chaperones in protein folding and proteostasis. Nature 475:324–332
Horwich AL, Fenton WA, Chapman E, Farr GW (2007) Two families of chaperonin: physiology and mechanism. Annu Rev Cell Dev Biol 23:115–145
Structure of Chaperonins: Ring-Shaped Oligomers
Fan M, Rao T, Zacco E, Ahmed MT, Shukla A, Ojha A, Freeke J, Robinson CV, Benesch JL, Lund PA (2012) The unusual mycobacterial chaperonins: evidence for in vivo oligomerization and specialization of function. Mol Microbiol 85:934–944
Chaperones and Autophagy
Arias E, Cuervo AM (2011) Chaperone-mediated autophagy in protein quality control. Curr Opin Cell Biol 23:184–189
Kaushik S, Cuervo AM (2012) Chaperones in autophagy. Pharmacol Res 66:484–493
Chaperones in Prevention of Aggregation of Defective Proteins
Athanasiou D, Kosmaoglou M, Kanuga N, Novoselov SS, Paton AW, Paton JC, Chapple JP, Cheetham ME (2012) BiP prevents rod opsin aggregation. Mol Biol Cell 23:3522–3531
Chaperones in Disaggregation of Protein Aggregates
Rosenzweig R, Moradi S, Zarrine-Afsar A, Glover JR, Kay LE (2013) Unraveling the mechanism of protein disaggregation through a ClpB-DnaK interaction. Science [Epub ahead of print] PMID: 23393091 [PubMed—as supplied by publisher]
Sharma SK, Christen P, Goloubinoff P (2009) Disaggregating chaperones: an unfolding story. Curr Protein Pept Sci 10:432–446
Winkler J, Tyedmers J, Bukau B, Mogk A (2012) Hsp70 targets Hsp100 chaperones to substrates for protein disaggregation and prion fragmentation. J Cell Biol 198:387–404
Zolkiewski M, Zhang T, Nagy M (2012) Aggregate reactivation mediated by the Hsp100 chaperones. Arch Biochem Biophys 520:1–6
Mitochondrial Chaperones
Tatsuta T (2009) Protein quality control in mitochondria. J Biochem 146:455–461
Voos W (2013) Chaperone-protease networks in mitochondrial protein homeostasis. Biochim Biophys Acta 1833:388–399. doi:10.1016/j.bbamcr.2012.06.005
Endoplasmic Reticulum (ER) Chaperones and ER-Associated Degradation (ERAD)
Benyair R, Ron E, Lederkremer GZ (2011) Protein quality control, retention, and degradation at the endoplasmic reticulum. Int Rev Cell Mol Biol 292:197–280
Ni M, Lee AS (2007) ER chaperones in mammalian development and human diseases. FEBS Lett 581:3641–3651
Suntharalingam A, Abisambra JF, O’Leary JC 3rd, Koren J 3rd, Zhang B, Joe MK, Blair LJ, Hill SE, Jinwal UK, Cockman M, Duerfeldt AS, Tomarev S, Blagg BS, Lieberman RL, Dickey CA (2012) Grp94 triage of mutant myocilin through ERAD subverts a more efficient autophagic clearance mechanism. J Biol Chem 287:40661–40669
Dedicated Chaperones
Szolajska E, Chroboczek J (2011) Faithful chaperones. Cell Mol Life Sci 68:3307–3322
Histone Chaperones
Burgess RJ, Zhang Z (2013) Histone chaperones in nucleosome assembly and human disease. Nat Struct Mol Biol 2013 Jan; 20(1):14–22. doi:10.1038/nsmb.2461
Extracellular Chaperones
De Maio A (2011) Extracellular heat shock proteins, cellular export vesicles, and the stress observation system: a form of communication during injury, infection, and cell damage. It is never known how far a controversial finding will go! Dedicated to Ferruccio Ritossa. Cell Stress Chaperones 16:235–249
Henderson B, Pockley AG (2010) Molecular chaperones and protein-folding catalysts as intercellular signaling regulators in immunity and inflammation. J Leukoc Biol 88:445–462
Sections 1.6–1.7 CHAPERONES AS CLINICALY USEFUL BIOMARKERS
Cappello F, Conway de Macario E, Zummo G, Macario AJL (2011) Immunohistochemistry of human Hsp60 in health and disease: from autoimmunity to cancer. Methods Mol Biol 787:245–254
The Value of Morphological-Topographic Data Obtained by Immunohistochemistry
Pellicciari C, Malatesta M (2011) Identifying pathological biomarkers: histochemistry still ranks high in the omics era. Eur J Histochem 55(4):e42; doi:10.4081/ejh.2011.e42
Colon Cancer
Cappello F, David S, Peri G, Farina F, Conway de Macario E, Macario AJL, Zummo G (2011) The human chaperonin Hsp60: molecular anatomy, role in carcinogenesis and potential for diagnosis and treatment of colorectal cancer. Front Biosci S3:341–351
Cappello F, David S, Rappa F, Bucchieri F, Marasa L, Bartolotta TE, Farina F, Zummo G (2005) The expression of Hsp60 and Hsp10 in large bowel carcinomas with lymph node metastase. BMC Cancer 28(5):139
Dundas SR, Lawrie LC, Rooney PH, Murray GI (2005) Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival. J Pathol 205:74–81
Hamelin C, Cornut E, Poirier F, Pons S, Beaulieu C, Charrier JP, Haïdous H, Cotte E, Lambert C, Piard F, Ataman-Önal Y, Choquet-Kastylevsky G (2011) Identification and verification of HSP60 as a potential serum marker for colorectal cancer. FEBS J 278:4845–4859. doi:10.1111/j.1742-4658.2011.08385.x
Lung Cancer
Cappello F, Di Stefano A, D’Anna SE, Donner CF, Zummo G (2005) Immunopositivity of heat shock protein 60 as a biomarker of bronchial carcinogenesis. Lancet Oncol 6:816
Cappello F, Di Stefano A, David S, Rappa F, Anzalone R, La Rocca G, D’Anna SE, Magno F, Donner CF, Balbi B, Zummo G (2006) Hsp60 and Hsp10 down-regulation predicts bronchial epithelial carcinogenesis in smokers with chronic obstructive pulmonary disease. Cancer 107:2417–2424
Xu X, Wang W, Shao W, Yin W, Chen H, Qiu Y, Mo M, Zhao J, Deng Q, He J (2011) Heat shock protein-60 expression was significantly correlated with the prognosis of lung adenocarcinoma. J Surg Oncol 104:598–603. doi:10.1002/jso.21992
Prostate Cancer
Cappello F, Rappa F, David S, Anzalone R, Zummo G (2003) Immunohistochemical evaluation of PCNA, p53, HSP60, Hsp10 and MUC-2 presence and expression in prostate carcinogenesis. Anticancer Res 23:1325–1331
Glaessgen A, Jonmarker S, Lindberg A, Nilsson B, Lewensohn R, Ekman P, Valdman A, Egevad L (2008) Heat shock proteins 27, 60 and 70 as prognostic markers of prostate cancer. APMIS 116:888–895
Cardiovascular Disease
Novo G, Cappello F, Rizzo M, Fazio G, Zambuto S, Tortorici E, Marino Gammazza A, Corrao S, Zummo G, Conway de Macario E, Macario AJL, Assennato P, Novo S, Li Volti G (2011) Hsp60 and Heme Oxygenase-1 (Hsp32) in acute myocardial infarction. Trans Res 157:285–292
Rizzo M, Macario AJL, Conway de Macario E, Gouni-Berthold I, Berthold H, Rini GB, Zummo G, Cappello F (2011) Heat-shock protein 60 and risk for cardiovascular disease. Curr Pharmaceutical Des 17:3662–3668
Inflammatory Bowel Disease
Rodolico V, Tomasello G, Zerilli M, Martorana A, Pitruzzella A, Gammazza AM, David S, Zummo G, Damiani P, Accomando S, Conway de Macario E, Macario AJL, Cappello F (2010) Hsp60 and Hsp10 increase in colon mucosa of Crohn’s disease and ulcerative colitis. Cell Stress Chaperones 15:877–884
Seigneuric R, Mjahed H, Gobbo J, Joly A-L, Berthenet K, Shirley S, Garrido C (2011) Heat shock proteins as danger signals for cancer detection. Front Oncol; 1:37, doi:10.3389/fonc.2011.00037
Sections 1.8 and 1.10 Chaperonotherapy and the Future
Abisambra JF, Jinwal UK, Jones JR, Blair LJ, Koren J 3rd, Dickey CA (2011) Exploiting the diversity of the heat-shock protein family for primary and secondary tauopathy therapeutics. Curr Neuropharmacol 9:623–631
Almeida MB, do Nascimento JL, Herculano AM, Crespo-López ME (2011) Molecular chaperones: toward new therapeutic tools. Biomed Pharmacother 65:239–243
Cappello F, Czarnecka AM, Rocca GL, Stefano AD, Zummo G, Macario AJL (2007) Hsp60 and Hsp10 as antitumor molecular agents. Cancer Biol Ther 6:487–489
Cappello F, Angileri F, Conway de Macario E, Macario AJL (2013) Chaperonopathies and chaperonotherapy. Hsp60 as therapeutic target in cancer: potential benefits and risks. Curr Pharm Des 19:452–457
Deocaris CC, Kaul SC, Wadhwa R (2009) The versatile stress protein mortalin as a chaperone therapeutic agent. Protein Pept Lett 16:517–529
Goloudina AR, Demidov ON, Garrido C (2012) Inhibition of HSP70: a challenging anti-cancer strategy. Cancer Lett 325:117–124
Kalmar B, Greensmith L (2009) Induction of heat shock proteins for protection against oxidative stress. Adv Drug Deliv Rev 61:310–318
Lee J, Tan CY, Lee SK, Kim YH, Lee KY (2009) Controlled delivery of heat shock protein using an injectable microsphere/hydrogel combination system for the treatment of myocardial infarction. J Control Release 137:196–202
Pace A, Barone G, Lauria A, Martorana A, Palumbo Piccionello A, Pierro P, Terenzi T, Almerico AM, Buscemi S, Campanella C, Angileri F, Carini F, Zummo G, Conway de Macario E, Cappello F, Macario AJL (2013) Hsp60, a novel target for antitumor therapy: Structure-function features and prospective drugs design. Curr Pharm Des 19:2757–2764
Raju M, Santhoshkumar P (2012) Sharma KK (2012) αA-Crystallin-derived mini-chaperone modulates stability and function of cataract causing αAG98R-Crystallin. PLoS ONE 7(9):e44077
Tan MH, Smith AJ, Pawlyk B, Xu X, Liu X, Bainbridge JB, Basche M, McIntosh J, Tran HV, Nathwani A, Li T, Ali RR (2009) Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors. Hum Mol Genet, 18:2099–2114. Erratum in. Hum Mol Genet 19(4):735
Vizcaychipi MP, Xu L, Barreto GE, Ma D, Maze M, Giffard RG (2011) Heat shock protein 72 overexpression prevents early postoperative memory decline after orthopedic surgery under general anesthesia in mice. Anesthesiology 114:891–900
White RE, Ouyang Y-B, Giffard R (2012) Hsp75/mortalin and protection from ischemic brain injury. In: Kaul SC, Wadhwa R (eds) Mortalin Biology: life, stress and death, Springer, Berlin, pp 179–190
Pharmacological Chaperones
Guce AI, Clark NE, Rogich JJ, Garman SC (2011) The molecular basis of pharmacological chaperoning in human α-galactosidase. Chem Biol 18:1521–1526
Chaperone Inhibitors
da Silva VC, Ramos CH (2012) The network interaction of the human cytosolic 90kDa heat shock protein Hsp90: A target for cancer therapeutics. J Proteomics 75:2790–2802
Gomez-Monterrey I, Sala M, Musella S, Campiglia P (2012) Heat shock protein 90 inhibitors as therapeutic agents. Recent Pat Anticancer Drug Discov 7:313–336
Lee CH, Hong HM, Chang YY, Chang WW (2012) Inhibition of heat shock protein (Hsp) 27 potentiates the suppressive effect of Hsp90 inhibitors in targeting breast cancer stem-like cells. Biochimie 94:1382–1389
Archaeal and Eukaryal Chaperones are evolutionary related and similar. Hence, Archaea have potential as experimental models simpler and, thus, more Amenable to dissection and analysis than Eukaryotic counterparts to study human Chaperones and the effect of mutations on them
Conway de Macario E, Maeder DL, Macario AJL (2003) Breaking the mould: Archaea with all four chaperoning systems. Biochem Biophys Res Commun 301:811–812
Large AT, Lund PA (2009) Archaeal chaperonins. Front Biosci 14:1304–1324. To see Table of Contents, Abstract, Figures and Tables go to: http://www.bioscience.org/2009/v14/af/3310/fulltext.htm
Luo H, Laksanalamai P, Robb FT (2009) An exceptionally stable group II chaperonin from the hyperthermophile Pyrococcus furiosus. Arch Biochem Biophys 486:12–18
Macario AJL, Conway de Macario E (2001) The molecular chaperone system and other anti-stress mechanisms in archaea. Front Biosci 6:d262–283. To see Table of Contents, Abstract and Figures go to: http://www.bioscience.org/2001/v6/d/macario/fulltext.htm
Maeder DL, Macario AJL, Conway de Macario E (2005) Novel chaperonins in a prokaryote. J Mol Evol 60:409–416
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2013 The Author(s)
About this chapter
Cite this chapter
Macario, A.J., Conway de Macario, E., Cappello, F. (2013). Overview and Book Plan. In: The Chaperonopathies. SpringerBriefs in Biochemistry and Molecular Biology. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4667-1_1
Download citation
DOI: https://doi.org/10.1007/978-94-007-4667-1_1
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4666-4
Online ISBN: 978-94-007-4667-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)